Skip to content
AwardedSpainGoods€440,300

SUMINISTRO DE LEBRIKIZUMAB (EBGLYSS®) DE DISTRIBUCIÓN EXCLUSIVA DEL LABORATORIO ALMIRALL, S.A. CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS

Published
Published 4 June 2026

Overview

Hospital Clínico San Carlos has awarded a contract to Laboratorio Almirall, S.A. for the supply of Lebrikizumab (Ebglyss®), an exclusively distributed pharmaceutical product, for the hospital's pharmacy service. The contract was awarded on 2 June 2026 for a value of €269,360.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€440,300
Procedure
Direct
Published
4 June 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€269,360
Award date
2 June 2026
Contract period
— → 24 November 2027
Winner
  • LOBORATORIO ALMIRALL, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    4 June 2026

Contracting authority

  • HOSPITAL CLINICO SAN CARLOS

    Procuring entity

    Madrid, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: SUMINISTRO DE LEBRIKIZUMAB (EBGLYSS®) DE DISTRIBUCIÓN EXCLUSIVA DEL LABORATORIO ALMIRALL, S.A. CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS — won by LOBORATORIO ALMIRALL, S.A. — Skim